Related Experiment Video
Updated: Jun 28, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Diuretics in hypertension
E Valvo1, A D'Angelo, G Maschio
1Institute of Nephrology, University Hospital of Verona, Italy.
Insights
Diuretics remain effective and cost-efficient for hypertension management. Low-dose diuretics offer a safe and viable first-line therapy option for hypertensive patients, despite newer drug availability.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Diuretics have historically been a cornerstone of hypertension treatment.
- Recent trends show a decline in diuretic use as first-line therapy.
- This decline is attributed to metabolic side effects and newer drug options.
Purpose of the Study:
- To re-evaluate the role of diuretics in hypertension management.
- To address the perception of newer agents having superior long-term cardiovascular outcomes.
- To highlight the benefits of low-dose diuretic therapy.
Main Methods:
- Review of clinical trial data on diuretics and cardiovascular events.
- Analysis of metabolic side effect profiles of diuretics versus newer agents.
- Assessment of safety, efficacy, and cost-effectiveness of diuretics.
Main Results:
- Diuretics consistently reduce stroke and coronary events in hypertensive patients.
- Many adverse effects of diuretics are dose-dependent and manageable with low doses.
- Limited long-term data exists for newer agents regarding cardiovascular end-points.
Conclusions:
- Diuretics should be considered a first-line therapy for hypertension.
- Low-dose diuretics offer a safe, effective, and cost-efficient treatment option.
- The efficacy and safety profile of diuretics support their continued use in hypertension management.
Abstract:
Despite the consistent reduction in the incidence of stroke and coronary events demonstrated in numerous clinical trials in young and elderly hypertensive subjects, the use of diuretics has declined as a first-line therapy in hypertension. The metabolic dose-dependent side effects and the increasing availability of new drugs appear the two main reasons for the decline. Although the neutral metabolic effects and the perception of a more physiological approach to hypertension has been advocated with the newer agents, no definite proof has been reported on the long-term effects on cardiovascular end-points. Many of adverse effects of diuretics can be limited by the use of low doses. For this reason, as well as their efficacy, safety, and cost-effectiveness, diuretics should remain a first-line therapy for hypertensive patients.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

